Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215772.RAPAGqFwi0P-cJWo-7T5K0mDzeOzZ17ARZJM-Wie2fMy4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215772.RAPAGqFwi0P-cJWo-7T5K0mDzeOzZ17ARZJM-Wie2fMy4130_assertion type Assertion NP1215772.RAPAGqFwi0P-cJWo-7T5K0mDzeOzZ17ARZJM-Wie2fMy4130_head.
- NP1215772.RAPAGqFwi0P-cJWo-7T5K0mDzeOzZ17ARZJM-Wie2fMy4130_assertion description "[CTCs were enumerated from peripheral blood samples collected from patients with each of the eight types of cancer; the detectability of CTCs for esophagus, pancreas and prostate cancers by the OBP-401 method was confirmed for the first time in the present study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215772.RAPAGqFwi0P-cJWo-7T5K0mDzeOzZ17ARZJM-Wie2fMy4130_provenance.
- NP1215772.RAPAGqFwi0P-cJWo-7T5K0mDzeOzZ17ARZJM-Wie2fMy4130_assertion evidence source_evidence_literature NP1215772.RAPAGqFwi0P-cJWo-7T5K0mDzeOzZ17ARZJM-Wie2fMy4130_provenance.
- NP1215772.RAPAGqFwi0P-cJWo-7T5K0mDzeOzZ17ARZJM-Wie2fMy4130_assertion SIO_000772 25176113 NP1215772.RAPAGqFwi0P-cJWo-7T5K0mDzeOzZ17ARZJM-Wie2fMy4130_provenance.
- NP1215772.RAPAGqFwi0P-cJWo-7T5K0mDzeOzZ17ARZJM-Wie2fMy4130_assertion wasDerivedFrom befree-2016 NP1215772.RAPAGqFwi0P-cJWo-7T5K0mDzeOzZ17ARZJM-Wie2fMy4130_provenance.
- NP1215772.RAPAGqFwi0P-cJWo-7T5K0mDzeOzZ17ARZJM-Wie2fMy4130_assertion wasGeneratedBy ECO_0000203 NP1215772.RAPAGqFwi0P-cJWo-7T5K0mDzeOzZ17ARZJM-Wie2fMy4130_provenance.